<乌鸦传媒>Metformin Protective Against Joint Replacement in Type 2 Diabetes Daily users saw lower risks for total knee, hip replacements Dec 19, 2022
<乌鸦传媒>It's a TNF Inhibitor! It's a Steroid! It's Two (Potential) RA Drugs in One! Hints in mid-stage trial that novel conjugate will surpass adalimumab in efficacy Dec 14, 2022
<乌鸦传媒>Xeljanz Cancer Risks Detailed New paper provides full results from ORAL Surveillance trial Dec 07, 2022
<乌鸦传媒>Common Treatments for Knee Osteoarthritis May Be Harmful Steroids and NSAIDs reduced pain but not disease course, studies showed Nov 30, 2022
<乌鸦传媒>Bone Drug Reverses Damage in Hand Osteoarthritis Provocative findings with denosumab, but don't reach for the prescription pad just yet Nov 15, 2022
<乌鸦传媒>Checkpoint Stimulator Passes Mid-Stage Test in Rheumatoid Arthritis Novel approach to normalizing immune activity Nov 14, 2022
<乌鸦传媒>Another Adalimumab Biosimilar Seems Set for Interchangeability Trial data pave way for FDA approval Nov 14, 2022
<乌鸦传媒>Want a Few Weeks of Knee Pain Relief? Try This Local nerve block proves mettle in randomized trial, though benefit didn't last long Nov 12, 2022
<乌鸦传媒>Chronic Pain: Opioids No Longer Treatment of Choice Nondrug therapies increased markedly in wake of 2016 CDC guidance Nov 07, 2022
<乌鸦传媒>New ACR/EULAR Guideline Expands RA Remission Definition Axial spondyloarthritis guidance also gets an update Oct 25, 2022
<乌鸦传媒>Does Rheumatoid Arthritis Get Its Start in the Gut? Patients and at-risk individuals show antibodies to common intestinal bacterium Oct 20, 2022
<乌鸦传媒>Is PMR the Next Indication for Tocilizumab? Phase III data suggest yes, albeit in a limited population and with several cautions Sep 20, 2022
<乌鸦传媒>Predicting Fractures in RA: Is FRAX Useful in the Modern Treatment Era? Algorithm held its own, but not many study patients were on biologics Sep 11, 2022
<乌鸦传媒>Pirfenidone Shows Hints of Benefit for RA-Related Lung Disease But early halt to recruitment, forced by pandemic, left trial underpowered Sep 06, 2022
<乌鸦传媒>Novel IL-6 Blocker Matches Humira in Rheumatoid Arthritis But is Russian backing a problem for U.S. approval? Aug 24, 2022
<乌鸦传媒>More Bad Safety News for Xeljanz Yet another risk confirmed in postmarketing study Aug 04, 2022
<乌鸦传媒>Lubricant Shots for Knee OA: No, They Really Don't Help Meta-analysis of hyaluronic acid trials throws serious shade on common practice Jul 06, 2022
<乌鸦传媒>Novel Anti-TNF Shines in Rheumatoid Arthritis Trial Trivalent "nanobody" biologic engineered to accumulate in inflamed tissue Jun 24, 2022
<乌鸦传媒>Guideline: Timing Is Everything for RA and Lupus Patients Needing Joint Replacement New advice on which antirheumatic meds to continue and which to stop before surgery Jun 21, 2022
<乌鸦传媒>Novel IL-17 Inhibitor Passes Mid-Stage Test in Psoriatic Arthritis Phase II results suggest drug could outperform existing agents Jun 03, 2022
<乌鸦传媒>Trial Upends Guidelines on Long-Term Steroids in Rheumatoid Arthritis Vindication for clinicians who ignored official recommendations Jun 03, 2022
<乌鸦传媒>Air Pollution and Illness: It's Not Just the Lungs and Heart Anymore Expanding range of conditions caused or aggravated by fine particulates Jun 01, 2022
<乌鸦传媒>Is Alzheimer's Risk Lower With TNF Inhibitors? For arthritis patients with cardiovascular disease, the answer may be yes Apr 08, 2022
<乌鸦传媒>'It's an Alien Knee in There': Mixed Feelings After Joint Replacement Study highlights common, but rarely discussed, problem Mar 28, 2022
<乌鸦传媒>Reassurance on Steroid Shots for Knee OA Study counters fears that injections worsen underlying pathology Mar 17, 2022
<乌鸦传媒>Ankylosing Spondylitis: Another Step Toward Individualized Therapy Study IDs factors predicting response to TNF inhibitors Mar 15, 2022
<乌鸦传媒>Hopes Dashed for Novel Osteoarthritis Treatment Noninvasive therapy looked like a sure winner until trial results came in Mar 08, 2022
<乌鸦传媒>Two Years On, Tremfya Still Shines in Psoriatic Arthritis Efficacy increases in long-term extension data Feb 10, 2022
<乌鸦传媒>Mystery: Why Would Hand OA Be Less Severe in Black People? Data contrast with previous findings for hip and knee osteoarthritis Feb 04, 2022
<乌鸦传媒>Trial Data Confirm Heightened Risks With JAK Inhibitor May help patients and clinicians better weigh benefit against adverse effects Jan 26, 2022
<乌鸦传媒>Muddled Picture for Antidepressant as Osteoarthritis Pain Reliever Trial in primary care setting fails to confirm benefit seen in specialty clinics Jan 06, 2022
<乌鸦传媒>Another Trial, Another PRP Flop in Osteoarthritis Fails to outperform saline in randomized trial Nov 23, 2021
<乌鸦传媒>Another Study Confirms Gout Benefit With SGLT2 Inhibitors Gout risk reduction was significantly better than with DPP-4 inhibitors Nov 19, 2021
<乌鸦传媒>Biologic Disappoints for Arthritis Achilles' Inflammation But phase III trial did find some patient-oriented benefits Nov 11, 2021
<乌鸦传媒>Vitamin D and Disease Prevention: Worth Another Look? Incidence of autoimmune disease decreased by 25-30% with dietary supplements Nov 08, 2021
<乌鸦传媒>Early Biologics Better in Juvenile Idiopathic Arthritis After 2 years, more patients on combo biologic/DMARD regimen had inactive disease Nov 08, 2021
<乌鸦传媒>No Love for PRP in Ankle Osteoarthritis Trial Dutch researchers throw cold water on popular therapy Oct 26, 2021
